These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 28649056)

  • 41. The impact of the injection mold temperature upon polymer crystallization and resulting drug release from immediate and sustained release tablets.
    Van Renterghem J; Dhondt H; Verstraete G; De Bruyne M; Vervaet C; De Beer T
    Int J Pharm; 2018 Apr; 541(1-2):108-116. PubMed ID: 29409747
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Polymers derived from Xanthomonas campesteris and Cyamopsis tetragonolobus used as retardant materials for the formulation of sustained release floating matrix tablet of atenolol.
    Dey S; Mazumder B; Chattopadhyay S; Das MK; Sinha S; Ganguly S; De K; Mishra M
    Int J Biol Macromol; 2014 Apr; 65():346-56. PubMed ID: 24472506
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Preparation and in vitro release of ginkgo biloba extract sustained-release tablets].
    Cui Q; Zhu Y; Cui J
    Zhongguo Zhong Yao Za Zhi; 2009 Aug; 34(15):1910-3. PubMed ID: 19894532
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Development and evaluation of a multiple-unit oral sustained release dosage form for S(+)-ibuprofen: preparation and release kinetics.
    Cox PJ; Khan KA; Munday DL; Sujja-areevath J
    Int J Pharm; 1999 Dec; 193(1):73-84. PubMed ID: 10581424
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Oral sustained release tablets of zidovudine using binary blends of natural and synthetic polymers.
    Emeje M; Olaleye O; Isimi C; Fortunak J; Byrn S; Kunle O; Ofoefule S
    Biol Pharm Bull; 2010; 33(9):1561-7. PubMed ID: 20823575
    [TBL] [Abstract][Full Text] [Related]  

  • 46. A new deferiprone controlled release system obtained by ultrasound-assisted compression.
    Aguilar-De-Leyva A; Gonçalves-Araujo T; Daza V; Caraballo I
    Pharm Dev Technol; 2014 Sep; 19(6):728-34. PubMed ID: 23984972
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Rheological characterization and drug release studies of gum exudates of Terminalia catappa Linn.
    Kumar SV; Sasmal D; Pal SC
    AAPS PharmSciTech; 2008; 9(3):885-90. PubMed ID: 18661243
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Biopharmaceutical evaluation of diclofenac sodium controlled release tablets prepared from gum karaya--chitosan polyelectrolyte complexes.
    Lankalapalli S; Kolapalli RM
    Drug Dev Ind Pharm; 2012 Jul; 38(7):815-24. PubMed ID: 22087874
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Controlled release hydrophilic matrix tablet formulations of isoniazid: design and in vitro studies.
    Hiremath PS; Saha RN
    AAPS PharmSciTech; 2008; 9(4):1171-8. PubMed ID: 19015997
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Gum Ghatti--a pharmaceutical excipient: development, evaluation and optimization of sustained release mucoadhesive matrix tablets of domperidone.
    Gurpreetarora ; Malik K; Rana V; Singh I
    Acta Pol Pharm; 2012; 69(4):725-37. PubMed ID: 22876617
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Native and microwave-modified Terminalia mantaly gums as sustained-release and bioadhesive excipients in naproxen matrix tablet formulations.
    Odeniyi MA; Oyedokun BM; Bamiro OA
    Polim Med; 2017; 47(1):35-42. PubMed ID: 29160627
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Formulation development and in-vitro/in-vivo correlation for a novel Sterculia gum-based oral colon-targeted drug delivery system of azathioprine.
    Nath B; Nath LK
    Drug Dev Ind Pharm; 2013 Nov; 39(11):1765-73. PubMed ID: 23110370
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Development of sustained and dual drug release co-extrusion formulations for individual dosing.
    Laukamp EJ; Vynckier AK; Voorspoels J; Thommes M; Breitkreutz J
    Eur J Pharm Biopharm; 2015 Jan; 89():357-64. PubMed ID: 25555454
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Formulation development and in vitro evaluation of theophylline microcapsules.
    Ahmad M; Akhtar N; Murtaza G; Hussain SW
    Pak J Pharm Sci; 2012 Jan; 25(1):15-9. PubMed ID: 22186304
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Formulation development and evaluation of lamivudine controlled release tablets using cross-linked sago starch.
    Singh AV; Nath LK
    Expert Opin Drug Deliv; 2013 Feb; 10(2):173-82. PubMed ID: 23241031
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Formulation and development of matrix tablets of tramadol using katira gum as release modifier.
    Singh I; Kumar P; Kumar S; Rana V
    Yakugaku Zasshi; 2010 Sep; 130(9):1225-31. PubMed ID: 20823680
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Microbead design for sustained drug release using four natural gums.
    Odeku OA; Okunlola A; Lamprecht A
    Int J Biol Macromol; 2013 Jul; 58():113-20. PubMed ID: 23541556
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Use of hydrophilic natural gums in formulation of sustained-release matrix tablets of tramadol hydrochloride.
    Varshosaz J; Tavakoli N; Kheirolahi F
    AAPS PharmSciTech; 2006 Mar; 7(1):E168-E174. PubMed ID: 28290039
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Effects of the method of preparation on the compression, mechanical, and release properties of khaya gum matrices.
    Odeku OA; Fell JT
    Pharm Dev Technol; 2006; 11(4):435-41. PubMed ID: 17101514
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Robustness of barrier membrane coated metoprolol tartrate matrix tablets: Drug release evaluation under physiologically relevant in vitro conditions.
    Klein S; Seeger N; Mehta R; Missaghi S; Grybos R; Rajabi-Siahboomi A
    Int J Pharm; 2018 May; 543(1-2):368-375. PubMed ID: 29630933
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.